Weight & GERD: The Mechanisms Linking Obesity to Reflux & How to Treat It

Obesity is the strongest modifiable risk factor for gastroesophageal reflux disease (GERD). The relationship is dose-dependent: higher BMI correlates with greater prevalence, severity, and complications of reflux. Understanding the mechanisms clarifies why weight loss is a cornerstone of GERD management.

Five Key Mechanisms

1. Elevated intra-abdominal pressure: Visceral adipose tissue mechanically compresses the stomach, increasing intragastric pressure and promoting transient LES relaxations (TLESRs)—the primary reflux mechanism.
2. LES dysfunction: Obesity reduces LES basal pressure and increases TLESR frequency. Hormonal factors (leptin, adiponectin) may impair sphincter tone.
3. Increased acid secretion: Visceral fat is pro-inflammatory; cytokines (IL-6, TNF-α) stimulate parietal cells. Higher BMI correlates with greater acid output.
4. Delayed gastric emptying: Obesity slows gastric motility, increasing gastric volume and pressure gradient across the LES.
5. Hiatal hernia: Obesity is the leading risk factor for hiatal hernia, which disrupts the anti-reflux barrier (crural diaphragm + LES). Hernia size correlates with BMI.

Weight Loss as Primary Therapy

Clinical trials demonstrate that 5–10% body weight loss significantly reduces:

• Esophageal acid exposure time (pH monitoring)
• Reflux symptom scores (GERD-HRQL, Reflux Disease Questionnaire)
• PPI dose requirements
• Hiatal hernia size (in some imaging studies)

Combined with dietary modification (low-fat, small meals), head-of-bed elevation, and avoidance of late eating, weight loss can achieve remission in mild-moderate GERD without medication.

Clinical Management Algorithm

1. Assess BMI, waist circumference, and GERD severity (symptoms, endoscopy, pH-impedance if needed).
2. Prescribe structured weight loss: caloric restriction (500–750 kcal deficit), high-protein/fiber, physical activity (150 min/week moderate).
3. Consider referral to registered dietitian, behavioral counseling, or bariatric evaluation if BMI ≥35 with comorbidities or ≥40.
4. Use PPIs as bridge therapy during weight loss; attempt step-down at 3–6 months if symptoms controlled.
5. Monitor for alarm symptoms; refer for endoscopy if dysphagia, weight loss, anemia, or refractory symptoms.

Bariatric Surgery Considerations

• Roux-en-Y gastric bypass (RYGB): Most effective for GERD resolution (diverts bile, reduces acid, eliminates gastric fundus).
• Sleeve gastrectomy: May worsen or induce GERD in some patients due to altered anatomy and increased intragastric pressure.
• Adjustable gastric band: Largely abandoned; high GERD exacerbation rates.

For overweight/obese patients with GERD, weight loss isn't just adjunctive—it's disease-modifying. Integrate it into every treatment plan.